{"id":"https://openalex.org/W4402561069","doi":"https://doi.org/10.1016/j.annonc.2024.08.1055","title":"996MO Dazostinag (TAK-676) alone and in combination with pembrolizumab (pembro) in patients (pts) with advanced/metastatic solid tumors: Data from phase I dose escalation","display_name":"996MO Dazostinag (TAK-676) alone and in combination with pembrolizumab (pembro) in patients (pts) with advanced/metastatic solid tumors: Data from phase I dose escalation","publication_year":2024,"publication_date":"2024-09-01","ids":{"openalex":"https://openalex.org/W4402561069","doi":"https://doi.org/10.1016/j.annonc.2024.08.1055"},"language":"en","primary_location":{"id":"doi:10.1016/j.annonc.2024.08.1055","doi":"https://doi.org/10.1016/j.annonc.2024.08.1055","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2024.08.1055","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://doi.org/10.1016/j.annonc.2024.08.1055","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5013575232","display_name":"J.J. Luke","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]},{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]},{"id":"https://openalex.org/I4210134769","display_name":"University of Pittsburgh Medical Center","ror":"https://ror.org/04ehecz88","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210098814","https://openalex.org/I4210134769"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J.J. Luke","raw_affiliation_strings":["Department of Medicine, Division of Hematology/Oncology, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Hematology/Oncology, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA","institution_ids":["https://openalex.org/I170201317","https://openalex.org/I4210128526","https://openalex.org/I4210134769"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089504168","display_name":"Xiang Gao","orcid":"https://orcid.org/0000-0002-6844-9651","observed_orcids":["https://orcid.org/0000-0002-6844-9651","https://orcid.org/0000-0001-8680-5296"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"X. Gao","raw_affiliation_strings":["Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital, Boston, MA, USA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076736008","display_name":"Anthony J. Olszanski","orcid":"https://orcid.org/0000-0001-5276-5898","observed_orcids":["https://orcid.org/0000-0001-5276-5898"]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A.J. Olszanski","raw_affiliation_strings":["Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I1289437631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070910784","display_name":"R.E. Sanborn","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R.E. Sanborn","raw_affiliation_strings":["Department of Oncology, Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069777765","display_name":"Gerald Steven Falchook","orcid":"https://orcid.org/0000-0001-9165-2191","observed_orcids":["https://orcid.org/0000-0001-9165-2191"]},"institutions":[{"id":"https://openalex.org/I4210120438","display_name":"HealthONE","ror":"https://ror.org/032y5sx52","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210120438"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G.S. Falchook","raw_affiliation_strings":["Drug Development Unit, Sarah Cannon Research Institute at HealthONE, Denver, CO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Development Unit, Sarah Cannon Research Institute at HealthONE, Denver, CO, USA","institution_ids":["https://openalex.org/I4210120438"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109732497","display_name":"S. Patel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039236","display_name":"Moores Cancer Center","ror":"https://ror.org/01qkmtm61","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959","https://openalex.org/I4390039236"]}],"countries":[],"is_corresponding":false,"raw_author_name":"S. Patel","raw_affiliation_strings":["Division of Hematology/Oncology, Department of Medicine, University of California San Diego Moores Cancer Center, La Jolla, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology/Oncology, Department of Medicine, University of California San Diego Moores Cancer Center, La Jolla, CA, USA","institution_ids":["https://openalex.org/I4390039236"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041145711","display_name":"Philippe Lucien Bedard","orcid":"https://orcid.org/0000-0002-6771-2999","observed_orcids":["https://orcid.org/0000-0002-6771-2999"]},"institutions":[{"id":"https://openalex.org/I1325899441","display_name":"University Health Network","ror":"https://ror.org/042xt5161","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"P.L. Bedard","raw_affiliation_strings":["Medical Oncology and Hematology Department, University Health Network, Toronto, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology and Hematology Department, University Health Network, Toronto, ON, Canada","institution_ids":["https://openalex.org/I1325899441"]}]},{"author_position":"middle","author":{"id":null,"display_name":"D. Orr","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087725","display_name":"Mary Crowley Cancer Research Center","ror":"https://ror.org/002ksg449","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210087725"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Orr","raw_affiliation_strings":["Oncology Department, Mary Crowley Cancer Research, Dallas, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Department, Mary Crowley Cancer Research, Dallas, TX, USA","institution_ids":["https://openalex.org/I4210087725"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011111764","display_name":"John P. Gibbs","orcid":"https://orcid.org/0000-0001-8892-7318","observed_orcids":["https://orcid.org/0000-0001-8892-7318"]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J.P. Gibbs","raw_affiliation_strings":["Quantitative Clinical Pharmacology, Takeda Development Center Americas, Inc. (TDCA), Lexington, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Quantitative Clinical Pharmacology, Takeda Development Center Americas, Inc. (TDCA), Lexington, MA, USA","institution_ids":["https://openalex.org/I4210140176"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070779283","display_name":"Chang Li","orcid":"https://orcid.org/0000-0002-7857-1028","observed_orcids":["https://orcid.org/0000-0002-7857-1028"]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. Li","raw_affiliation_strings":["Statistical and Quantitative Sciences, Takeda Development Center Americas, Inc. (TDCA), Lexington, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Statistical and Quantitative Sciences, Takeda Development Center Americas, Inc. (TDCA), Lexington, MA, USA","institution_ids":["https://openalex.org/I4210140176"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Y-C. Huang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Y-C. Huang","raw_affiliation_strings":["Statistical and Quantitative Sciences, Takeda Development Center Americas, Inc. (TDCA), Lexington, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Statistical and Quantitative Sciences, Takeda Development Center Americas, Inc. (TDCA), Lexington, MA, USA","institution_ids":["https://openalex.org/I4210140176"]}]},{"author_position":"middle","author":{"id":null,"display_name":"R. Gregory","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Gregory","raw_affiliation_strings":["Statistical and Quantitative Sciences, Takeda Development Center Americas, Inc. (TDCA), Lexington, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Statistical and Quantitative Sciences, Takeda Development Center Americas, Inc. (TDCA), Lexington, MA, USA","institution_ids":["https://openalex.org/I4210140176"]}]},{"author_position":"middle","author":{"id":null,"display_name":"R. Ramesh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Ramesh","raw_affiliation_strings":["PTM, Takeda Development Center Americas, Inc. (TDCA), Lexington, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PTM, Takeda Development Center Americas, Inc. (TDCA), Lexington, MA, USA","institution_ids":["https://openalex.org/I4210140176"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102790528","display_name":"Ruizhe Xu","orcid":"https://orcid.org/0009-0007-8193-4292","observed_orcids":["https://orcid.org/0009-0007-8193-4292"]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Xu","raw_affiliation_strings":["Statistical and Quantitative Sciences, Takeda Development Center Americas, Inc. (TDCA), Lexington, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Statistical and Quantitative Sciences, Takeda Development Center Americas, Inc. (TDCA), Lexington, MA, USA","institution_ids":["https://openalex.org/I4210140176"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101811710","display_name":"B. Wu","orcid":"https://orcid.org/0009-0003-4065-9539","observed_orcids":["https://orcid.org/0009-0003-4065-9539"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B. Wu","raw_affiliation_strings":["Statistics, Takeda Development Center Americas, Inc. (TDCA), Lexington, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Statistics, Takeda Development Center Americas, Inc. (TDCA), Lexington, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"K. Ding","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K. Ding","raw_affiliation_strings":["PTM, Takeda Development Center Americas, Inc. (TDCA), Lexington, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PTM, Takeda Development Center Americas, Inc. (TDCA), Lexington, MA, USA","institution_ids":["https://openalex.org/I4210140176"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029952866","display_name":"Jeffrey J. Raizer","orcid":"https://orcid.org/0009-0003-8469-2509","observed_orcids":["https://orcid.org/0009-0003-8469-2509"]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Raizer","raw_affiliation_strings":["Oncology Development, Takeda Development Center Americas, Inc. (TDCA), Lexington, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Development, Takeda Development Center Americas, Inc. (TDCA), Lexington, MA, USA","institution_ids":["https://openalex.org/I4210140176"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5064953304","display_name":"Patricia Mucci LoRusso","orcid":"https://orcid.org/0000-0001-7144-036X","observed_orcids":["https://orcid.org/0000-0001-7144-036X"]},"institutions":[{"id":"https://openalex.org/I2802730090","display_name":"Yale Cancer Center","ror":"https://ror.org/03j7sze86","country_code":"US","type":"facility","lineage":["https://openalex.org/I2802730090","https://openalex.org/I4210117499","https://openalex.org/I4210165192"]},{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P. Lorusso","raw_affiliation_strings":["Department of Internal Medicine, Medical Oncology, Yale Cancer Center, New Haven, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Medical Oncology, Yale Cancer Center, New Haven, CT, USA","institution_ids":["https://openalex.org/I2802730090","https://openalex.org/I32971472"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":12,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4600,"currency":"USD","value_usd":4600},"apc_paid":null,"fwci":0.7642,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.73708448,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":98},"biblio":{"volume":"35","issue":null,"first_page":"S678","last_page":"S679"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9082000255584717,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9082000255584717,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11668","display_name":"interferon and immune responses","score":0.0544000007212162,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.02669999934732914,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sting-agonist","display_name":"STING agonist","score":0.9459999799728394},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9120000004768372},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitor-combination-therapy","display_name":"immune checkpoint inhibitor combination","score":0.7009999752044678},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.843999981880188},{"id":"https://openalex.org/keywords/metastatic-cancer","display_name":"metastatic cancer","score":0.8040000200271606},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.7770000100135803},{"id":"https://openalex.org/keywords/innate-and-adaptive-immunity","display_name":"innate and adaptive immunity","score":0.49900001287460327},{"id":"https://openalex.org/keywords/cytokine-response","display_name":"cytokine response","score":0.6990000009536743}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9026130437850952},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.7137084007263184},{"id":"https://openalex.org/C2993640289","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Solid tumor","level":3,"score":0.4274286925792694},{"id":"https://openalex.org/C44280652","wikidata":"https://www.wikidata.org/wiki/Q104837","display_name":"Phase (matter)","level":2,"score":0.41048741340637207},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.39222294092178345},{"id":"https://openalex.org/C2989005","wikidata":"https://www.wikidata.org/wiki/Q214963","display_name":"Nuclear medicine","level":1,"score":0.35503512620925903},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3387302756309509},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.21643662452697754},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.08715000748634338},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.annonc.2024.08.1055","doi":"https://doi.org/10.1016/j.annonc.2024.08.1055","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2024.08.1055","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.annonc.2024.08.1055","doi":"https://doi.org/10.1016/j.annonc.2024.08.1055","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2024.08.1055","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.49000000953674316,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2585407512","https://openalex.org/W3037068108","https://openalex.org/W2059423835","https://openalex.org/W2945780494","https://openalex.org/W3041652591","https://openalex.org/W2517747645","https://openalex.org/W2062691140","https://openalex.org/W3114060412","https://openalex.org/W2521234799","https://openalex.org/W2969843676"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":4}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2025-10-10T00:00:00"}